§ Federal grant opportunity · PAR-24-129
Limited Competition: Specific Pathogen Free Macaque Colonies to Support HIV/AIDS Research (U42 Clinical Trial Not Allowed)
National Institutes of Health is accepting applications for Limited Competition: Specific Pathogen Free Macaque Colonies to Support HIV/AIDS Research (U42 Clinical Trial Not Allowed). The deadline is September 25, 2026 and the published award range is Award amount not published.
Key facts
- Funder
- National Institutes of Health
- Application deadline
- September 25, 2026
- Award range
- Award amount not published
- Eligibility
- Other Eligible Applicants include the following:Non-domestic (non-U.S.) Entities (Foreign Organization) are not eligible to apply.Non-domestic (non-U.S.) components of U.S. Organizations are not eligible to apply.Foreign components, as defined in the NIH Grants Policy Statement, are not allowed. see NOFO for eligibility details
- Geography
- United States
- Focus areas
- Health
- Opportunity number
- PAR-24-129
Program overview
The purpose of this Notice of Funding Opportunity (NOFO) is to provide continuing support for specific pathogen-free (SPF) macaque colonies previously funded under the auspices of PAR-21-089 and PAR-18-669 that support Human Immunodeficiency Virus (HIV)/Acquired Immunodeficiency Syndrome (AIDS) research. Breeding colonies are essential to sustain appropriate SPF macaques for research related to HIV/AIDS. Pedigree SPF macaques are free of certain viruses, which may confound the results of HIV/AIDS-related investigations or present a risk to the personnel who care for the animals. The SPF macaques are genetically characterized for major histocompatibility complex (MHC) class I types, because MHC class I genotypes have large effects on macaque immune responses to Simian Immunodeficiency Virus (SIV) that can induce AIDS in nonhuman primates (NHPs) and on human immune responses to HIV.
How to apply
- Confirm your organization meets the eligibility criteria above.
- Read the full funding opportunity announcement from National Institutes of Health.
- Draft your narrative against the funder's stated priorities and review criteria.
- Submit before September 25, 2026, allowing time for registration and validation.
Related grant opportunities
- Metastasis Research Network (U54 Clinical Trial Not Allowed)
- F27AS00008-NAWCA 2027-1 US Standard Grants
- National Cancer Institute Youth Enjoy Science Research Education Program (R25 Clinical Trial Not Allowed)
- FY26 Bureau of Land Management Plant Conservation and Restoration Management - Bureau wide
- Coordinating Agricultural Development & Innovation (CADI) to enable America First Trade Wins in Europe, the South Caucasus and Central Asia
Find every grant your organization qualifies for
Mavenly scores this opportunity against your mission, geography, and funding history — then drafts the proposal with you and tracks the deadline through submission and reporting.